Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention-Reference-Cited by-同舟云学术

Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention

Published:2019-03-07 Issue:12 Volume:68 Page:2144-2153
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Revolinski Sara Lynn¹²^ORCID,Munoz-Price L Silvia³

Affiliation:

1. Department of Pharmacy, Froedtert and the Medical College of Wisconsin, Froedtert Hospital, Milwaukee

2. School of Pharmacy, Department of Medicine, Medical College of Wisconsin, Milwaukee

3. Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/12/2144/28739287/ciy845.pdf

Reference49 articles.

1. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients;Alonso;Clin Infect Dis,2012

2. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period;Aldrete;Transpl Infect Dis,2017

3. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors;Alonso;Biol Blood Marrow Transplant,2013

4. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: a single-center study in Quebec, Canada;Lavallee;Transpl Infect Dis,2016

5. A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients;Alonso;Transpl Infect Dis,2017

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections;Clinical Microbiology Reviews;2024-09-12

2. Evaluation of MALDI-TOF mass spectrometry coupled with ClinProTools as a rapid tool for toxin-producing Clostridioides difficile;Journal of Infection and Chemotherapy;2024-09

3. Scutellaria baicalensis Georgi alleviates Clostridium difficile associated diarrhea and its modulatory effects on the gut microbiota;Fitoterapia;2024-07

4. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options;Clinical Microbiology Reviews;2024-06-13

5. Impact of colon cancer on outcomes in hospitalized patients with Clostridioides difficile infection: a national inpatient analysis;Baylor University Medical Center Proceedings;2024-05-15